AAPL238.47+1.85%MSFT428.91+0.73%NVDA142.65+2.31%AAPL238.47+1.85%MSFT428.91+0.73%NVDA142.65+2.31%
Quotes powered by Intrinio. Last updated .
Research Library

Earnings

Q1 Earnings: 7 Companies That Beat Expectations

Apr 28, 2026 · 17 min read · Winvestor Analyst Team

Q1 2026 reporting season delivered a handful of standout results from companies the market had largely written off. We highlight seven names where the underlying business is inflecting and the share price has yet to catch up.

Margins are the story this quarter

Revenue growth across the S&P 500 came in roughly in line at 4.8% year-over-year, but operating margin expansion of 110 basis points materially exceeded expectations. The dispersion was extreme — the top quintile of companies expanded margins by 300+ bps while the bottom quintile saw compression. We focused our work on the inflecting middle.

The setup heading into the quarter

Consensus expectations were positioned defensively after two quarters of mixed prints. Beat rates on revenue were running at the lowest level since 2020, and guidance had been broadly trimmed in January. That setup created an unusually low bar for the operationally inflecting names. Companies that simply met internal plans were rewarded with double-digit single-day stock reactions — a clear sign of how negatively positioned the market had become.

Seven names worth a closer look

Without naming specific tickers in this excerpt, the common threads across our seven beats are: (1) two years of cost discipline finally flowing through to incrementals, (2) pricing power that survived the post-inflation reset, (3) a mix shift toward higher-margin recurring revenue, and (4) capital allocation that has meaningfully reduced share count. Our full table for members includes entry prices, target prices, and downside scenarios.

The recurring revenue tailwind

Five of the seven names we highlighted have grown their recurring revenue base by 15%+ annually for three consecutive years. The market continues to multiple-cap these businesses as if they were transactional. Each time recurring revenue passes 50% of total revenue, multiples historically re-rate by 200-400 bps of EV/EBITDA. Several of our names sit just below that threshold today.

Capital allocation as a competitive advantage

Three of our seven have reduced share count by more than 25% over five years at average prices well below current levels. This is not financial engineering — it is the rare combination of high incremental returns on capital and the discipline to return excess cash when reinvestment opportunities are scarce. The aggregate effect on per-share metrics is profound and has been a meaningful driver of compounding for long-term holders.

What we got wrong

Two of our coverage names disappointed materially. In both cases the underlying thesis remains intact, but execution timing has slipped roughly two quarters. We maintain our positions but have flagged elevated near-term volatility to members.

Reading across to the rest of the year

If Q1 is representative, the full-year setup for S&P 500 EPS growth is closer to 12-14% than the 9% consensus expects. That meaningfully changes the valuation conversation — at 19x forward earnings on a higher EPS base, the index looks materially less stretched than headline multiples suggest. We are leaning long quality cyclicals and selectively trimming defensives where multiples have re-rated despite tepid fundamentals.